MARKET

PSTX

PSTX

Poseida Therapeutics, Inc.
NASDAQ
3.220
-0.020
-0.62%
After Hours: 3.300 +0.08 +2.48% 19:19 03/15 EDT
OPEN
3.180
PREV CLOSE
3.240
HIGH
3.440
LOW
3.170
VOLUME
934.64K
TURNOVER
0
52 WEEK HIGH
4.520
52 WEEK LOW
1.540
MARKET CAP
310.69M
P/E (TTM)
-2.3528
1D
5D
1M
3M
1Y
5Y
Poseida: April 2024 Data Could Shed Light On Differentiated CAR-T Advancement
Poseida Therapeutics is expected to release results from the phase 1 study using P-BCMA-ALLO1 for the treatment of patients with relapsed/refractory multiple myeloma on April 8th of 2024. The company has the backing of Roche to advance its CAR-T program. The global multiple myleoma market size is projected to reach $31 billion by 2026.
Seeking Alpha · 2d ago
Poseida spikes after FDA orphan status for CAR-T therapy
Healthcare Poseida spikes after FDA orphan status for CAR-T therapy. Shares of Poseida Therapeutics (NASDAQ:PSTX) traded higher on Wednesday. The FDA granted its orphan drug designation for a car-T cell therapy candidate developed by the company. The designation covers its use for multiple myeloma.
Seeking Alpha · 5d ago
Poseida Therapeutics Down Over 15%, on Pace for Largest Percent Decrease Since March 2023 -- Data Talk
Poseida Therapeutics, Inc. ( PSTX ) is currently at $3.44, down $0.63 or 15.36% -- On pace for largest percent decrease since March 10, 2023. Currently down four of the past six days. Down 78.8% from its all-time closing high.
Dow Jones · 03/11 18:43
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Mesoblast shares jumped 13.4% to $2.4399 on Monday. The company announced FDA support of an accelerated approval pathway for end-stage heart failure patients. Kidpik Corp. Shares gained 238% in today's mid-day session.
Benzinga · 03/11 17:41
12 Health Care Stocks Moving In Monday's Intraday Session
Regencell Bioscience (NASDAQ:RGC) shares rose 130.9% to $10.39 during Monday's regular session. The company's market cap stands at $135.2 million. TC BioPharm (Holdings) shares increased by 76.41% during the session. Mesoblast stock rose 22.79% and Graphite Bio stock moved upwards.
Benzinga · 03/11 17:31
ELTK, PSTX and LTRN among mid-day movers
Seeking Alpha · 03/11 16:49
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
U.S. Stocks were lower on Monday, with the Dow Jones index falling more than 150 points. Shares of EQT Corporation fell sharply after the company announced a merger agreement to acquire Equitrans Midstream. Ventyx Biosciences, Inc. Shares tumbled 18.5% to $8.09.
Benzinga · 03/11 14:37
Weekly Report: what happened at PSTX last week (0304-0308)?
Weekly Report · 03/11 09:07
More
About PSTX
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. The Company’s approach to cell and gene therapies is based on its genetic editing platforms, including its non-viral piggyBac DNA Delivery System, Cas-CLOVER Site-Specific Gene Editing System and nanoparticle and hybrid gene delivery technologies. Its P-MUC1C-ALLO1 is an allogeneic CAR-T product candidate with the potential to treat a range of solid tumor indications, including breast and other epithelial-derived cancers. Its product candidate, P-PSMA- ALLO1, is being developed for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). Its product candidate P-BCMA-ALLO1 and P-BCMACD19-ALLO1 is developed for patients with multiple myeloma. Its P-CD19CD20-ALLO1 is an allogeneic, CAR-T product candidate in preclinical development for B cell leukemia and lymphoma indications.

Webull offers Poseida Therapeutics Inc stock information, including NASDAQ: PSTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSTX stock methods without spending real money on the virtual paper trading platform.